ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for the quarter ending 2023-03-31 was $67.09K, a 45.38% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for the quarter ending 2022-03-31 was $46.15K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for the quarter ending 2021-06-30 was $57.73K, a 1.91% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for the quarter ending 2020-06-30 was $58.85K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for fiscal 2022 was $46.15K, a 20.06% decline from fiscal 2021.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for fiscal 2021 was $57.73K, a 1.92% decline from fiscal 2020.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for fiscal 2020 was $58.85K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, conversion of units for fiscal 2017 was $113.14K, a 63.34% decline from fiscal 2016.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2023-03-31 | $67.09K 10-Q · filed 2023-12-29 | |
| 2022-12-31 | $46.15K 10-K · filed 2023-04-17 | |
| 2022-03-31 | $46.15K 10-Q · filed 2023-12-29 | |
| 2021-12-31 | $57.73K 10-K · filed 2023-04-17 | |
| 2021-06-30 | $57.73K 10-Q · filed 2021-11-19 | |
| 2020-12-31 | $58.85K 10-K · filed 2021-04-13 | |
| 2020-06-30 | $58.85K 10-Q · filed 2021-11-19 | |
| 2017-12-31 | $46.77K derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-04-15 | $113.14K 10-K · filed 2019-04-15 |
| 2017-09-30 | -$1.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | $14.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | |
| 2017-03-31 | $51.53K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $308.61K 10-K · filed 2017-04-17 |